Neurosurgical FOCUS,
Journal Year:
2018,
Volume and Issue:
45(5), P. E4 - E4
Published: Nov. 1, 2018
OBJECTIVEPrognostication
and
surgical
planning
for
WHO
grade
I
versus
II
meningioma
requires
thoughtful
decision-making
based
on
radiographic
evidence,
among
other
factors.
Although
conventional
statistical
models
such
as
logistic
regression
are
useful,
machine
learning
(ML)
algorithms
often
more
predictive,
have
higher
discriminative
ability,
can
learn
from
new
data.
The
authors
used
an
array
of
ML
to
predict
atypical
radiologist-interpreted
preoperative
MRI
findings.
goal
this
study
was
compare
the
performance
standard
methods
when
predicting
grade.METHODSThe
cohort
included
patients
aged
18-65
years
with
(n
=
94)
34)
in
whom
obtained
between
1998
2010.
A
board-certified
neuroradiologist,
blinded
histological
grade,
interpreted
all
MR
images
tumor
volume,
degree
peritumoral
edema,
presence
necrosis,
location,
a
draining
vein,
patient
sex.
trained
validated
several
binary
classifiers:
k-nearest
neighbors
models,
support
vector
machines,
naïve
Bayes
classifiers,
artificial
neural
networks
well
grade.
area
under
curve-receiver
operating
characteristic
curve
comparison
across
within
model
classes.
All
analyses
were
performed
MATLAB
using
MacBook
Pro.RESULTSThe
6
imaging
demographic
variables:
sex,
vein
construct
models.
outperformed
true-positive
false-positive
(receiver
characteristic)
space
(area
0.8895).CONCLUSIONSML
powerful
computational
tools
that
great
accuracy.
CA A Cancer Journal for Clinicians,
Journal Year:
2019,
Volume and Issue:
69(2), P. 127 - 157
Published: Feb. 5, 2019
Abstract
Judgement,
as
one
of
the
core
tenets
medicine,
relies
upon
integration
multilayered
data
with
nuanced
decision
making.
Cancer
offers
a
unique
context
for
medical
decisions
given
not
only
its
variegated
forms
evolution
disease
but
also
need
to
take
into
account
individual
condition
patients,
their
ability
receive
treatment,
and
responses
treatment.
Challenges
remain
in
accurate
detection,
characterization,
monitoring
cancers
despite
improved
technologies.
Radiographic
assessment
most
commonly
visual
evaluations,
interpretations
which
may
be
augmented
by
advanced
computational
analyses.
In
particular,
artificial
intelligence
(AI)
promises
make
great
strides
qualitative
interpretation
cancer
imaging
expert
clinicians,
including
volumetric
delineation
tumors
over
time,
extrapolation
tumor
genotype
biological
course
from
radiographic
phenotype,
prediction
clinical
outcome,
impact
treatment
on
adjacent
organs.
AI
automate
processes
initial
images
shift
workflow
management
whether
or
administer
an
intervention,
subsequent
observation
yet
envisioned
paradigm.
Here,
authors
review
current
state
applied
describe
advances
4
types
(lung,
brain,
breast,
prostate)
illustrate
how
common
problems
are
being
addressed.
Although
studies
evaluating
applications
oncology
date
have
been
vigorously
validated
reproducibility
generalizability,
results
do
highlight
increasingly
concerted
efforts
pushing
technology
use
future
directions
care.
British Journal of Radiology,
Journal Year:
2020,
Volume and Issue:
93(1108)
Published: Feb. 26, 2020
Historically,
medical
imaging
has
been
a
qualitative
or
semi-quantitative
modality.
It
is
difficult
to
quantify
what
can
be
seen
in
an
image,
and
turn
it
into
valuable
predictive
outcomes.
As
result
of
advances
both
computational
hardware
machine
learning
algorithms,
computers
are
making
great
strides
obtaining
quantitative
information
from
correlating
with
Radiomics,
its
two
forms
“handcrafted
deep,”
emerging
field
that
translates
images
data
yield
biological
enable
radiologic
phenotypic
profiling
for
diagnosis,
theragnosis,
decision
support,
monitoring.
Handcrafted
radiomics
multistage
process
which
features
based
on
shape,
pixel
intensities,
texture
extracted
radiographs.
Within
this
review,
we
describe
the
steps:
starting
data,
how
extracted,
correlate
clinical
outcomes,
resulting
models
used
make
predictions,
such
as
survival,
detection
classification
diagnostics.
The
application
deep
learning,
second
arm
radiomics,
place
workflow
discussed,
along
advantages
disadvantages.
To
better
illustrate
technologies
being
used,
provide
real-world
applications
oncology,
showcasing
research
well
covering
limitations
future
direction.
Abdominal Radiology,
Journal Year:
2019,
Volume and Issue:
44(6), P. 1960 - 1984
Published: May 2, 2019
From
diagnostics
to
prognosis
response
prediction,
new
applications
for
radiomics
are
rapidly
being
developed.
One
of
the
fastest
evolving
branches
involves
linking
imaging
phenotypes
tumor
genetic
profile,
a
field
commonly
referred
as
"radiogenomics."
In
this
review,
general
outline
radiogenomic
literature
concerning
prominent
mutations
across
different
sites
will
be
provided.
The
radiogenomics
originates
from
image
processing
techniques
developed
decades
ago;
however,
many
technical
and
clinical
challenges
still
need
addressed.
Nevertheless,
increasingly
accurate
robust
models
presented
future
appears
bright.
European Journal of Nuclear Medicine and Molecular Imaging,
Journal Year:
2019,
Volume and Issue:
46(13), P. 2656 - 2672
Published: June 18, 2019
The
aim
of
this
systematic
review
was
to
analyse
literature
on
artificial
intelligence
(AI)
and
radiomics,
including
all
medical
imaging
modalities,
for
oncological
non-oncological
applications,
in
order
assess
how
far
the
image
mining
research
stands
from
routine
application.
To
do
this,
we
applied
a
trial
phases
classification
inspired
drug
development
process.
Among
articles
considered
inclusion
PubMed
were
multimodality
AI
radiomics
investigations,
with
validation
analysis
aimed
at
relevant
clinical
objectives.
Quality
assessment
selected
papers
performed
according
QUADAS-2
criteria.
We
developed
criteria
studies.
Overall
34,626
retrieved,
300
applying
inclusion/exclusion
criteria,
171
high-quality
(QUADAS-2
≥
7)
identified
analysed.
In
27/171
(16%),
141/171
(82%),
3/171
(2%)
studies
an
AI-based
algorithm,
model,
combined
radiomics/AI
approach,
respectively,
described.
A
total
26/27(96%)
1/27
(4%)
classified
as
phase
II
III,
respectively.
Consequently,
13/141
(9%),
10/141
(7%),
111/141
(79%),
7/141
(5%)
0,
I,
II,
All
three
categorised
trials.
results
are
promising
but
still
not
mature
enough
tools
be
implemented
setting
widely
used.
transfer
learning
well-known
process,
some
specific
adaptations
discipline
could
represent
most
effective
way
algorithms
become
standard
care
tools.
Scientific Reports,
Journal Year:
2021,
Volume and Issue:
11(1)
Published: March 9, 2021
Tumor
histology
is
an
important
predictor
of
therapeutic
response
and
outcomes
in
lung
cancer.
Tissue
sampling
for
pathologist
review
the
most
reliable
method
classification,
however,
recent
advances
deep
learning
medical
image
analysis
allude
to
utility
radiologic
data
further
describing
disease
characteristics
risk
stratification.
In
this
study,
we
propose
a
radiomics
approach
predicting
non-small
cell
cancer
(NSCLC)
tumor
from
non-invasive
standard-of-care
computed
tomography
(CT)
data.
We
trained
validated
convolutional
neural
networks
(CNNs)
on
dataset
comprising
311
early-stage
NSCLC
patients
receiving
surgical
treatment
at
Massachusetts
General
Hospital
(MGH),
with
focus
two
common
histological
types:
adenocarcinoma
(ADC)
Squamous
Cell
Carcinoma
(SCC).
The
CNNs
were
able
predict
AUC
0.71(p
=
0.018).
also
found
that
using
machine
classifiers
such
as
k-nearest
neighbors
(kNN)
support
vector
(SVM)
CNN-derived
quantitative
features
yielded
comparable
discriminative
performance,
up
0.71
(p
0.017).
Our
best
performing
CNN
functioned
robust
probabilistic
classifier
heterogeneous
test
sets,
qualitatively
interpretable
visual
explanations
its
predictions.
Deep
based
can
identify
phenotypes
It
has
potential
augment
existing
approaches
serve
corrective
aid
diagnosticians.
CNS Oncology,
Journal Year:
2021,
Volume and Issue:
10(2)
Published: May 21, 2021
Meningiomas
are
the
most
common
primary
intracranial
tumors.
The
majority
of
meningiomas
benign,
but
they
can
present
different
grades
dedifferentiation
from
grade
I
to
III
(anaplastic/malignant)
that
associated
with
outcomes.
Radiological
surveillance
is
a
valid
option
for
low-grade
asymptomatic
meningiomas.
In
other
cases,
treatment
usually
surgical,
aimed
at
achieving
complete
resection.
use
adjuvant
radiotherapy
gold
standard
III,
debated
II
and
not
generally
indicated
radically
resected
systemic
treatments
standardized.
Here
we
report
review
literature
on
clinical,
radiological
molecular
characteristics
meningiomas,
available
strategies
ongoing
clinical
trials.
Neuro-Oncology,
Journal Year:
2018,
Volume and Issue:
21(Supplement_1), P. i44 - i61
Published: Oct. 18, 2018
The
archetypal
imaging
characteristics
of
meningiomas
are
among
the
most
stereotypic
all
central
nervous
system
(CNS)
tumors.
In
era
plain
film
and
ventriculography,
was
only
performed
if
a
mass
suspected,
their
results
were
more
suggestive
than
definitive.
Following
century
technological
development,
we
can
now
rely
on
to
non-invasively
diagnose
meningioma
with
great
confidence
precisely
delineate
locations
these
tumors
relative
surrounding
structures
inform
treatment
planning.
Asymptomatic
may
be
identified
growth
monitored
over
time;
moreover,
routinely
serves
as
an
essential
tool
survey
tumor
burden
at
various
stages
during
course
treatment,
thereby
providing
guidance
effectiveness
or
need
for
further
intervention.
Modern
radiological
techniques
expanding
power
from
detection
monitoring
include
extraction
biologic
information
advanced
analysis
parameters.
These
contemporary
approaches
have
led
promising
attempts
predict
grade
and,
in
turn,
contribute
prognostic
data.
this
supplement
article,
review
important
current
future
aspects
diagnosis
management
meningioma,
including
conventional
using
CT,
MRI,
nuclear
medicine.